Home >> Industry News >> Thermo Fisher to sell anatomic pathology business

Thermo Fisher to sell anatomic pathology business

image_pdfCreate PDF

Feb. 4, 2019—Thermo Fisher Scientific announced it has signed a definitive agreement to sell its anatomical pathology business to PHC Holdings Corp. for approximately $1.14 billion. The company’s AP business is a provider of microscope slides, instruments, and consumables and employs approximately 1,200 people in the United States, Europe, and China. PHC Holdings develops, manufactures, sells, and services medical equipment and solutions for the diabetes care, diagnostics, life sciences, and health care IT industries.

CAP TODAY
X